Yayın: Towards Novel Anti-tumor Strategies for Hepatic Cancer: ɛ-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells
| dc.contributor.author | ÖZDEMİR, FİLİZ | |
| dc.contributor.author | Akalın, Gülşen | |
| dc.contributor.author | İşcan, A. | |
| dc.contributor.author | Şen, Mesut | |
| dc.contributor.author | Kutlu, Hatice Mehtap | |
| dc.contributor.author | Önder, Nur İpek | |
| dc.contributor.author | İncesu, Zerrin | |
| dc.contributor.orcid | 0000-0002-3359-4496 | |
| dc.contributor.orcid | 0000-0003-2366-2114 | |
| dc.contributor.orcid | 0000-0002-8816-1487 | |
| dc.date.accessioned | 2025-11-13T10:04:49Z | |
| dc.date.issued | 2013-12-17 | |
| dc.identifier.doi | https://doi.org/10.1089/omi.2013.0045 | |
| dc.identifier.endpage | 334 | |
| dc.identifier.issn | 1536-2310 | |
| dc.identifier.issue | 5 | |
| dc.identifier.openalex | W1121555848 | |
| dc.identifier.startpage | 324 | |
| dc.identifier.uri | https://hdl.handle.net/11421/3057 | |
| dc.identifier.uri | https://doi.org/10.1089/omi.2013.0045 | |
| dc.identifier.volume | 18 | |
| dc.language.iso | en | |
| dc.relation.ispartof | OMICS A Journal of Integrative Biology | |
| dc.rights | openAccess | |
| dc.subject | Vincristine | |
| dc.subject | Apoptosis | |
| dc.subject | Propidium iodide | |
| dc.subject | MTT assay | |
| dc.subject | Chemistry | |
| dc.subject | Pharmacology | |
| dc.subject | Agarose gel electrophoresis | |
| dc.subject | Cell growth | |
| dc.subject | IC50 | |
| dc.subject | Viability assay | |
| dc.subject | Cancer research | |
| dc.subject | Cancer cell | |
| dc.subject | DNA fragmentation | |
| dc.subject | Cancer | |
| dc.subject | Molecular biology | |
| dc.subject | Programmed cell death | |
| dc.subject | Medicine | |
| dc.subject | Biology | |
| dc.subject | In vitro | |
| dc.subject | Internal medicine | |
| dc.subject | Biochemistry | |
| dc.subject | Chemotherapy | |
| dc.subject | DNA | |
| dc.subject.sdg | 3 | |
| dc.title | Towards Novel Anti-tumor Strategies for Hepatic Cancer: ɛ-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5101741378 | |
| local.authorid.openalex | A5032209233 | |
| local.authorid.openalex | A5041879703 | |
| local.authorid.openalex | A5062007809 | |
| local.authorid.openalex | A5080074713 | |
| local.authorid.openalex | A5080166391 | |
| local.authorid.openalex | A5088833074 |
